Medtronic plcMDTNYSE
Loading
Cost of Revenue Over TimeStable
Percentile Rank100
3Y CAGR+4.7%
5Y CAGR+4.3%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+4.7%/yr
vs +2.8%/yr prior
5Y CAGR
+4.3%/yr
Consistent
Acceleration
+1.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
3 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $11.63B | +3.7% |
| 2024 | $11.22B | +4.6% |
| 2023 | $10.72B | +5.7% |
| 2022 | $10.14B | -3.2% |
| 2021 | $10.48B | +11.2% |
| 2020 | $9.42B | +2.9% |
| 2019 | $9.15B | +1.0% |
| 2018 | $9.07B | -2.4% |
| 2017 | $9.29B | +1.7% |
| 2016 | $9.14B | - |